The Magnafield system maybe useful for the following: • Pain - from migraine headaches . to troubled feet (temporary relief) Over the past 10-years, Altered States have helped thousands of people free themselves of back pain, arthritic pain, muscle spasms, sciatic pain and more. Back pain Back pain can occur for no apparent reason and at any point on your spine. The most common site for pain is your lower back because it bears the most weight and stress. Back injuries are a common cause of disability. And even though back pain is rarely life-threatening, the annual cost in terms of lost productivity, medical expenses and workers' compensation benefits runs into the tens of billions of dollars annually in the United States. Although back pain is common, it's also quite possible for you to prevent
most back problems with simple steps such as exercise and adopting new ways
to sit and stand. Even if you've injured your back before, you can learn techniques
to help avoid recurrent injuries. TENS stimulates sensory nerves to block pain signals, stimulate endorphin production to help normalize sympathetic function. Our products are used for the following conditions: Common uses: Prevent atrophy, strengthening programs/toning, reeducate muscles, increase range of motion, joint replacement, gait training, shoulder subluxation, reduction of muscle spasms and much more. For more information, please Common uses: relax muscles, relieve pain and soreness in arthritic joints, relieve hand pain, treat carpal tunnel syndrome, back pain, relieve stress and much more. portable multifrequencie pain control stress and pain But pain killers now in use have drawbacks. Morphine, codeine and related drugs, given by mouth or intravenously, can cause such side effects as nausea, constipation and itching. Epidural blocks can lead to similar problems. In addition, they must usually be removed before the patient goes home, even though he or she may still be in pain. Berde has found that many people are reluctant to take pain medication at home, or give it to their children, in the mistaken fear that they will become addicts. *The most important setting is 0.5Hz. This has the best benefit in nearly all cases, and is the most recommended frequency for initial treatments. For certain conditions it is the only setting to obtain the required benefits. Each frequency has specific effects. EVERY HOME SHOULD HAVE ONE THE SIGNAL goes to the spinal cord, where it passes instantaneously to a motor nerve (1) connected to a muscle in the leg. This causes a reflex action that does not involve the brain. But the signal also goes up the spinal cord to the thalamus (2), where the pain is perceived pain spots for treatment patches can be placed directly over the area in pain. Alternatively, one or
more of the patches can be placed on any of the acupressure points outlined
here by red dots. Pain,15, 94, 304, 727,787,880 Interferential electrical stimulation's is a unique way of effectively delivering therapeutic frequencies to tissue. Conventional TENS and Neuromuscular stimulators use discrete electrical pulses delivered at low frequencies of 2-160 Hz per second. However, Interferential stimulators use a fixed carrier frequency of 4,000 Hz per second and also a second adjustable frequency of 4,001-4,400 Hz per second. The pain mode consists of a short ramp of .01 seconds. a frequency of 30 Hz,
and a current of 80-100 microamps. The pain mode is always followed by the
ETR (Enhancement of Tissue Repair) or healing mode. The ETR mode consists of
a longer ramp of 2 seconds. a frequency of .3 Hz and a current of 20-40 microamps.
An average treatment includes 10 minutes on the pain mode followed by 10-20
minutes on she ETR mode. Treatment should be performed every other day, or
daily for optimal results. But as with all natural-born researchers, Goodheart finally found by instinct and experimentation that the correct frequency was 300 Hz. He determined that very little power is required, usually 20 µA is sufficient and the time of 20 seconds is what he is using. It may work as will at 20 seconds, and 60 seconds doesn't seem to be any better, so a time of 30 seconds was selected. As George always says, "It Works!" tapping precordial or electrical stimulation at 300 Hz can also be used. Pg 136: "The Ear Force and Acupuncture": "... The major Purring the Pain Away It has been shown that physiological and pathological conditions can induce release of neuropeptides. Two well-known examples are a severe painful stimulus inducing the release of opioid peptides to ease pain, and sucking of the nipples promoting the secretion of milk. Oxytocinergic neurons fire at a very low rate, of ~1 Hz (0.1–2.6 Hz) in basal conditions, but prolonged sucking by ten or more pups can bring the firing rate up to 16–50 Hz, followed by strong milk ejection within 10–12 seconds [3]. This finding suggests that neuropeptide release could be modulated by external stimulation. Clinically, intracranial [4] or intra-spinal [5] electrical stimulation has been used through neurosurgical procedures to provide relief for patients suffering from chronic pain, with a success rate of 50–80% after one year of treatment. This pain-relief effect could involve the release of neuropeptides [6], raising the attractive possibility that non-invasive methods might be used to modulate neuropeptide release for therapeutic intervention. The question is, would such an approach be effective and practical? Frequency-dependent neuropeptide release in vitro In isolated rat neurohypophyses, field electrical stimulation induces the
release of arginine vasopressin (AVP) and oxytocin (OT) into the incubation
medium. Stimulation at a frequency such as 15–30 Hz was much more effective
than a lower frequency such as 2–3 Hz in triggering peptide release [7],
and burst stimulation was more effective than constant-frequency stimulation
[8]. Furthermore, in superfused rat spinal cord slices, the release of the
neuropeptide substance P (SP) per pulse of electrical stimulation was increased
by frequencies in the range of 20–50 Hz, whereas release of the small-molecule
neurotransmitter 5-hydroxytryptamine (5-HT) per pulse remained constant [9].
Hokfelt proposed that peptide release requires bursting or high-frequency activities,
whereas individual action potentials firing at a low frequency will not induce
the release of peptides [10,11] . The facilitation of peptide release by high-frequency
stimulation was considered to be due to the lengthening of the action potential
duration, together with the increase in frequency, leading to an increase in
Ca2+ entry and in the amount of secretion per unit of action potential [12].
This concept has been supported by more recent reports [13]. However, frequency
requirement can vary for different neuropeptides. In a similar experimental
setting, thyrotropin-releasing hormone (TRH) could be released by electrical
stimulation at a frequency as low as 0.5 and 3 Hz [14].
TAKEN FROM PHYSICAL THERAPY FORUM APRIL 30 1993
The internationally known radiologist and researcher, Bjorn Nordenstrom, describes tissues as biologic batteries in our body. This concept is well known and accepted by many researchers. Nordenstrom believes that an electrical voltage potential difference exists in the body that is created by a separation of oppositely charged ions. He states that the electrical energy of this biologic battery can be tapped once its closed. The closed circuit permits the flow of electricity between oppositely charged areas. In his book on bioelectricity, Nordenstrom describes the activation of these biological semiconductor circuits following muscle activity and injuries both of which cause a build-up of positively charged ions. Researchers have benefited greatly from the discovery that the body functions in a micro-current level. Scientific studies utilizing micro-currents have documented its ability to reduce pain, stimulate and even shorten the healing process. Research by Cheng, at the university of Louvain in Belgium, have shown that a current of 500 micro-amperes can raise the adenosine triphosphate (ATP) level almost 500% and increase protein synthesis and membrane transport. The Bourguignon study documented the intracellular influx of calcium within the first min. Of micro-current stimulation followed by an uncapping of insulin receptors on the cell membrane and enhancement of protein and DNA synthesis. Nessler and Mass in their study used seven micro-amperes of direct current to speed tissue repair and regeneration of excised rabid tendon. Histologic examination confirmed the tenoblastic repair had been enhanced by electrical stimulation. Pain Control Mechanism Pressure exerted on nerve tissue is the major cause of pain. Pain is an exceptionally strong signal that warns us that something is wrong. It may be a signal recorded from our skin touch receptors and from internal receptors located in our muscles, joints and organs. Pain warnings are necessary for our survival, as they activate our body to protect us from danger. However, when pain persists and we know its cause, we are able to apply therapy to the pressure causing the problem, and stimulation to alleviate the pain we are caused to feel from the pressure upon nerves. As many people develop cycles of "pain-spasm-more pain," the breaking of a pain cycle enables the body to recover more rapidly. Electronic Aspirin The analgesia obtained using T.E.N.S. is like an Electronic Aspirin. This analgesia occurs by activation of pain control mechanisms that cause an endorphin release, an encephalin release and a gating effect, to suppress or shut off pain signals from reaching the brain. This has a hormonal effect of suppressing pain-conducting signals at nerve junctions and to Unlearn the Feeling of Pain. Endorphin Release The Medication Effect An endorphin release has a slow acting effect. T.E.N.S. is applied at a low repetition (pulse) rate of less than ten pulses per second. The introduced electrical stimulation activates neural potentials within C type sensory nerve fibers, which transmit at the slow rate of the Autonomic Nervous System, to activate the body’s main pain defense mechanism. C type stimulation requires a longer application time of twenty five minutes to two hours to reach a maximum level of endorphin release, but because endorphins remain at effective levels in the blood stream for extended periods, a pain relief period of up to thirty six hours may be achieved. Sustained stimulation at low levels of pulse intensity has the strongest effect on managing chronic nagging pain. Experience has shown that for the management of chronic pain, an endorphin release is by far the most effective application of T.E.N.S. Endorphins flow through the circulatory system acting like pain medication, inhibiting pain message transmission at nerve junctions throughout the body. Endorphins, because of their analgesic medication type action, induces an analgesic effect that relieves other aches and pains, as well as the primary pain for which T.E.N.S. is applied. It is worth noting that Morphine is a clone of endorphin and acts on the same reception center in the CNS. The strong pain management effect of morphine is also available from endorphins, which have a more powerful pain management effect than non-opiate advanced medication. An endorphin release occurs at a slow, deferred function similar in effect to medication in the blood stream, so repeated three times daily doses of T.E.N.S. pain management may be required. The effect of an endorphin release may last much longer in the elderly. Gating Effect and Encephalin Release A gating effect obtained using T.E.N.S. is a quick acting effect. It occurs because the introduced stimulation acts as a counter to the stimulus causing the pain, by blocking it from registering. It switches off painful sensations at hypothetical pain control gates in the CNS, thereby achieving a pseudo mechanical effect known as gating or blanketing. The theory of gating is that a pain control gate is closed by the hyper-activation of neural sensory potentials within A type nerve fibers, which overrides the slow velocity pain conducting neural potentials transmitted in the C type fibers. The function of A type sensory nerve fibers is to transmit reflex action potentials, other urgent messages of pain, other strong warning signals and skeletal muscle action messages at high velocities. This high velocity enables the use of high pulse rates of 100 to 400 pps to maximize a strong gating effect. A gating effect is achieved using short periods of strong stimulation. This is the most common form of electrical induced analgesia, but it is not necessarily the best, because it only controls pain for a short period. An encephalin release also occurs in response to hyper activation of A type sensory nerve fibers. Encephalins act similarly to endorphins by flowing within the blood stream and have a short medication type life cycle of less than two hours. A gating and encephalin release is required for strong acute pain management and in exceptional circumstances the condition may need ongoing pain management. Endorphin Release, Gating Effect and Encephalin Release A combined endorphin release, an encephalin release and a gating effect are all achieved at the same time by changing the rate of the stimuli to A, B and C type sensory nerve fibers, with a combined low and a high modulated (changing) rate stimuli. This induces a very effective short and long term pain management, which is a frequently used method of controlling pain. By Maggie Fox. They said men who had suffered one heart attack and who had antibodies to Chlamydia pneumoniae were four times more likely to suffer second heart attacks. Treating them for the infection lowered the risk. The findings, published in the American Heart Association journal Circulation, add to a growing body of evidence that heart attacks may sometimes be due to infection rather than genetics or lifestyle. "We know that antibodies seem to be linked to heart disease," Dr. Sandeep Gupta at St. George's Hospital Medical School in London, who led the study, said in a telephone interview. In addition, the chlamydia bacteria, which cause a chest infection and which are a close relative of a common sexually transmitted disease, have turned up in the fatty plaques that line clogged arteries. Gupta's British Heart Foundation team joined the race of researchers trying to establish a more than circumstantial link between the bug and heart attacks. His team took 213 survivors of heart attacks and divided them into three groups according to how many chlamydia antibodies they had in their blood. They watched for heart attacks for 18 months. "The group of heart patients with negative antibodies, they had an approximately seven percent event rate over 18 months,'' Gupta said. Those with intermediate levels of antibodies had double that risk, while those with high antibody levels -- meaning bigger chlamydia infection -- had a 28 percent ``event rate'' of heart attacks. That was four times the risk of the group that had no antibodies. "But the guys that had high antibodies and also got antibiotics, their risk went down to eight percent," Gupta added. They were given a single three-day course of azithromycin, although Gupta said he believed several antibiotics such as tetracycline would also have worked. "This is a small study," Gupta noted. He said his team would now start a two-year study with 2,500 volunteers. "I don't think we are in a position yet to tell people you should be having antibiotics. No way,'' he added. Gupta said he thought chlamydia was causing inflammation, which in turn caused blood clots. The chlamydia was somehow crossing into the arteries, he added. Immune system cells could be the key. "It's a lung infection but it's found in the coronary,'' he said. "It may be transported in the monocyte, the warrior, the white cell." Activated monocytes produce a chemical on their surface known as tissue factor. Meant to be part of the healing process, it can help trigger blood clotting. Chlamydia was a logical culprit because it was so insidious, Gupta added. It could lurk in the body a long time, causing few symptoms but a lot of damage. "If you look at other chlamydia species, it's the commonest cause of infertility in the USA," he said. "It causes inflammation of the Fallopian tubes and then it causes scarring." With another chlamydial infection, trachoma, blindness is caused in a similar way by scarring eye tissue. If antibiotics could help even a small percentage of people with heart disease,
many lives would be saved by something as easy as taking a few tablets, Gupta
said. SKIN CANCER Scientists from the ICRF have found that up to 50 per cent of immunosuppressed kidneytransplant patients develop skin tumours and all of them are indeed with a new human papilloma virus (H They believe the virus may predispose cells to being damaged by UV sun rays. CERVICAL CANCER Women with cervical cancer have been found to lack antibodies to a protein (E2) produced by HPV type 16 which is found in 95 per cent of cervical tumours. Their immune system thus does not recognize HPV-infected cells as foreign. Smoking, which increases the risk of cervical cancer is also thought to reduce immune system ability to eliminate HPV. US researchers have launched human trials of an HPV vaccine. LEUKAEMIA The Institute of Public Health in Cambridge reported last month that Iymphocytic leukemia - the commonest type of cancer in children - could be caused by a seasonal virus. After studying 4,000 cases, they found people were 40 per cent more likely to be diagnosed with the condition between May and October. RHEUMATOID ARTHRITIS Chlamydia pneumonae has been isolated in the inflamed joints of people with rheumatoid arthritis. Antibiotic trials have improved pain and mobility. CROHN'S DISEASE Researchers at the Royal Free Hospital, London believe chronic infection with measles virus causes Crohn's Disease. They have found live virus in ulcerated parts of the colon and suggest it is periodically triggered into adion, causing an immune response that causes long-term damage to blood vessels in the bowel lining. MENTAL ILLNESS Research suggests that chemical agents produced when the immune system attacks a virus can affect the brain. These chemicals have been implicated in various psychiatric disorders. People with glandular fever, which is linked to pathogens such as Epstein Barr virus, have four times the risk of developing clinical depression. PARKINSON'S DISEASE Researchers in Leeds suggest Parkinson's could be due to a virus which enters the central nervous system through the nose (up to 90 per cent of Parkinson's patients lose their sense of smell). Studies in mice show viruses introduced through the nose spread rapidly in the brain.
|
